JavaScript is disabled for your browser. Some features of this site may not work without it.
Please be advised that the site will be down for maintenance on Sunday, September 1, 2024, from 08:00 to 18:00, and again on Monday, September 2, 2024, from 08:00 to 09:00. We apologize for any inconvenience this may cause.
Mathematical assessment of the role of waning and boosting immunity against the BA.1 Omicron variant in the United States
Safdar, Salman; Ngonghala, Calistus N.; Gumel, Abba B.
Three safe and effective vaccines against SARS-CoV-2 have played a major role in combating
COVID-19 in the United States. However, the effectiveness of these vaccines and vaccination
programs has been challenged by the emergence of new SARS-CoV-2 variants of concern. A new
mathematical model is formulated to assess the impact of waning and boosting of immunity against
the Omicron variant in the United States. To account for gradual waning of vaccine-derived immunity,
we considered three vaccination classes that represent high, moderate and low levels of immunity. We
showed that the disease-free equilibrium of the model is globally-asymptotically, for two special cases,
if the associated reproduction number is less than unity. Simulations of the model showed that vaccinederived
herd immunity can be achieved in the United States via a vaccination-boosting strategy which
entails fully vaccinating at least 59% of the susceptible populace followed by the boosting of about
72% of the fully-vaccinated individuals whose vaccine-derived immunity has waned to moderate or
low level. In the absence of boosting, waning of immunity only causes a marginal increase in the
average number of new cases at the peak of the pandemic, while boosting at baseline could result in
a dramatic reduction in the average number of new daily cases at the peak. Specifically, for the fast
immunity waning scenario (where both vaccine-derived and natural immunity are assumed to wane
within three months), boosting vaccine-derived immunity at baseline reduces the average number of
daily cases at the peak by about 90% (in comparison to the corresponding scenario without boosting
of the vaccine-derived immunity), whereas boosting of natural immunity (at baseline) only reduced
the corresponding peak daily cases (in comparison to the corresponding scenario without boosting of
natural immunity) by approximately 62%. Furthermore, boosting of vaccine-derived immunity is more beneficial (in reducing the burden of the pandemic) than boosting of natural immunity. Finally, boosting vaccine-derived immunity increased the prospects of altering the trajectory of COVID-19 from
persistence to possible elimination.
Description:
The Simons Foundation, the National Science Foundation and the Fulbright Foreign Student Program.